Shreyash Devalkar of Axis Mutual Fund advises careful investment. Pharma faces neutral impact from US tariffs. IT sector experiences global valuation reset. Defence shows growth due to scarcity premium. IPO boom signals market diversification. Consumption focuses on GST cuts and festive season. Market awaits earnings recovery into 2025. Investors should track earnings sustainability beyond festive demand.
Limited impact of tariff on pharma, IT under pressure; IPOs & defence in focus: Shreyash Devalkar
September 26, 2025
Recent Post
ARC Insulation IPO allotment date likely today. GMP, steps to check share allotment status online
August 26, 2025
Stock market holiday: Is the Indian stock market open or closed on Ganesh Chaturthi 2025?
August 26, 2025
Japan’s Nikkei ends at over 2-week low as yen gains after Trump fires Fed’s Cook
August 26, 2025
Have Any Question?
Do not hesitate to contact us. We’re a team of experts ready to talk to you.
